NeoGenomics Inc (NEO)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -107,736 | -157,623 | -118,754 | -13,992 | 13,006 |
| Revenue | US$ in thousands | 601,638 | 508,222 | 479,247 | 436,029 | 404,099 |
| Operating profit margin | -17.91% | -31.01% | -24.78% | -3.21% | 3.22% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-107,736K ÷ $601,638K
= -17.91%
Neogenomics Inc.'s operating profit margin has shown significant fluctuations over the past five years. The company experienced a negative operating profit margin in all years except for 2019. The margins ranged from -30.04% in 2022 to 3.18% in 2019, indicating inconsistent operational efficiency and profitability.
The downward trend from 2019 to 2022 suggests challenges in managing operational expenses relative to revenue generation during those years. However, there was a slight improvement in 2020, with the operating profit margin reaching -3.15%.
The most recent data for 2023 shows a further decline in the operating profit margin to -16.34%, indicating a deterioration in the company's ability to generate profits from its core business operations.
Overall, Neogenomics Inc.'s operating profit margin performance raises concerns about its operational efficiency and profitability, signaling a need for potential cost management and revenue enhancement strategies to improve its financial performance in the future.